Researchers at the University of Colorado Anschutz Medical Campus have investigated how antiviral proteins called interferons interact with SARS-CoV-2, the cause of COVID-19. The study, published in ...
Researchers have examined five SARS-CoV-2 variants to determine how each strain interacts with the innate arm of the immune system -- the first line of defense in the immune system versus the antibody ...
In a study of lab-engineered cells, researchers identify how the immune system neutralizes the herpesvirus. The research maps, for the first time, the maneuvers used by virus and host in the cell ...
In a recent study published in PNAS, researchers compared the potency of 17 human interferons (IFNs) against multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. Recent SARS ...
Known as first responders to viral infection, Type I interferons may also play a part—for better or worse—in neurodegenerative disease. At AD/PD 2022, held March 15-20 online and in Barcelona, Spain, ...
Research presented by Professor Cecilia Johansson of Imperial College London has linked early type I interferon signalling in ...
Authors of a systematic review in this week's issue of THE LANCET highlight how interferons--widely used to treat multiple sclerosis--have no proven effect beyond one year of treatment. Interferons ...
Herpes simplex virus (HSV) is extremely common, affecting nearly two-thirds of the world’s population, according to the World Health Organization. Once inside the body, HSV establishes a latent ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback